Overview
Hypothesis: Treatment with the hydrophilic coated valved intraurethral catheter up to 16 hours per day is effective, well tolerated and seemingly safe for treatment of women with stress incontinence.
Test persons: Ten to twenty stress incontinent women. Treatment time: Up to two weeks
Description
Demonstrate ease and comfort of device insertion, indwelling and removal. Patient acceptability during use.
- Other
-
- Symptom and QOL questionnaire.
- Drop out analysis.
- Is the patient motivated to continue using the valve catheter?
- Is the patient motivated to recommend the valve catheter to other stress incontinent women?
Eligibility
Inclusion Criteria:
- Willing to participate
- Adult, competent woman who understands Danish.
- SUI as dominant symptom; daily or almost daily.
- Residual urine < 150 ml.
- POP-Q prolapse ≤ grade 2.
- Negative urine stix/Urine D+R.
- Min. 2 months local vaginal estrogen treatment if the woman is postmenopausal.
- Mobile and self-reliant woman.
- Motivated.
Exclusion Criteria:
- Allergy to the silicone material
- Pregnancy or breastfeeding
- Unexplained hematuria.
- Current inflammatory disorders
- Malignant disorders of the urethra.
- Urethral stricture
- Visual diverticulum.
- AK treatment.
- Prosthetic heart valve surgery.